Acute anemic events in sickle cell disease

Transfusion

Volumn 40, Issue 3, 2000, Pages 267-273

  Reed, William ^a   Walker, P ^b   Haddix, T ^b   Perkins, H A ^b  

^a Blood Centers of the Pacific   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY;

ADULT; AUTOPSY; BLOOD TRANSFUSION; CASE REPORT; CONFERENCE PAPER; FEMALE; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HEMOLYSIS; HUMAN; PREGNANCY; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SPLENOMEGALY; THROMBOCYTE COUNT;

ACUTE DISEASE; ADULT; ANEMIA; ANTI-BACTERIAL AGENTS; CEREBRAL HEMORRHAGE; CLOSTRIDIUM INFECTIONS; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; MICROCIRCULATION; PREGNANCY; SICKLE CELL TRAIT; SPLEEN;

EID: 0034022402     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030267.x     Document Type: Conference Paper

References (39)

1. Powars D. Natural history of sickle cell disease - the first ten years. Semin Hematol 1975;12:267-85.
2. Platt O, Brambilla D, Rosse W, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
3. Reed W, Vichinsky E. New considerations in the treatment of sickle cell disease. Annu Rev Med 1998;49:461-74.
4. Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997;337:1584-90.
5. Styles L, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen-4 and CD36 on reticulocytes in patients treated with hydroxyurea. Blood 1997;89:2554-9.
6. Solovey A, Gui L, Hebbel R. Tissue factor expression by endothetial cells in sickle cell anemia. J Clin Invest 1998;101:1899-904.
7. Charache S, Termin M, Moore R. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;322:1317-22.
8. Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996;88:1960-4.
9. Walters M, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996;335:369-76.
10. Kelly P, Kurtzberg J, Vichinsky E, Lubin B. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr 1997;130:695-703.
11. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
12. Cohen A. Sickle cell disease - new treatments, new questions (editorial). N Engl J Med 1998;339:42-4.
13. Serjeant G. Chronic transfusion programmes in sickle cell disease: problem or panacea? Br J Haematol 1997;97:253-5.
14. Isola J, DeVries S, Chu L, et al. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994;145:1301-8.
15. Chaplin H Jr, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981;141:1091-3.
16. Sosler SD, Perkins JT, Saporito C, et al. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease (abstract). Transfusion 1989;29(Suppl):49S.
17. Castellino SM, Combs MR, Zimmerman MA, et al. Erythrocyte autoantibodies in pediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics, and significance. Br J Haematol 1999;104:189-94.
18. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
19. Diamond WJ, Brown FL Jr, Bitterman P, et al. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med 1980;93:231-4.
20. King K, Shirey R, Lankiewicz M, et al. Delayed hemolytic reactions in sickle cell disease: simultaneous destruction of recipient's red cells. Transfusion 1997;37:376-81.
21. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987;69:820-6.
22. Conley CL, Lippman SM, Ness PM, et al. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med 1982;306:281-6.
23. a, characterizing a blood group of high incidence. Br J Haematol 1956;2:333-6.
24. Spring F, Gardner B, Anstee D. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992;80:2136-41.
25. aantibody in a Yt(a+) patient. Vox Sang 1994;66:130-2.
26. a blood group antigen and is reduced or absent in the Yt(a-b-) phenotype. Blood 1993;81:815-9.
27. Bartels C, Zelinski T, Lockridge O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for the Yt blood group polymorphism. Am J Hum Genet 1993;52:928-36.
28. Reid M, Francis C. The Yt blood group system. Blood Group Antigen Facts Book. London: Academic Press, 1997:250.
29. Test ST, Woolworth VS. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood 1994;83:842-52.
30. Garratty G. Severe reactions associated with transfusion in patients with sickle cell disease. Transfusion 1997;37:357-61.
31. Emond A, Collins R, Darvill D. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985;107:201-6.
32. Buchanan G, Glader B. Benign course of extreme hyperbilirubinemia in sickle cell anemia: analysis of six cases. J Pediatr 1977;91:21-4.
33. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997;89:1787-92.
34. Brown K, Young N. Parvovirus B19 in human disease. Annu Rev Med 1997;48:59-67.
35. Batge B, Filejski W, Kurowski V, et al. Clostridial sepsis with massive intravascular hemolysis: rapid diagnosis and successful treatment. Intensive Care Med 1992;18:488-90.
36. Lane P, O'Connell J, Lear J, et al. Functional asplenia in hemoglobin SC disease. Blood 1995;85:2238-44.
37. Bernini J, Mustafa M, Sutor L, Buchanan G. Fatal hemolysis induced by ceftriaxone in a child with sickle cell disease. J Pediatr 1995;126:813-5.
38. Garratty G, Postaway N, Schwellenbach J, McMahill P. A fatal case of ceftriaxone-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176-9.
39. Ohene-Frempong K, Weiner S, Sleeper L, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.